Hexagon Capital Partners’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-61
| Closed | -$26.5K | – | 544 |
|
|
2025
Q1 | $26.5K | Buy |
61
+18
| +42% | +$7.83K | 0.01% | 653 |
|
|
2024
Q4 | $15.9K | Sell |
43
-52
| -55% | -$19.2K | ﹤0.01% | 873 |
|
|
2024
Q3 | $49.4K | Buy |
95
+30
| +46% | +$15.6K | 0.01% | 457 |
|
|
2024
Q2 | $35.2K | Buy |
65
+1
| +2% | +$542 | 0.01% | 516 |
|
|
2024
Q1 | $33.2K | Sell |
64
-11
| -15% | -$5.7K | 0.01% | 527 |
|
|
2023
Q4 | $35.4K | Buy |
75
+29
| +63% | +$13.7K | 0.01% | 490 |
|
|
2023
Q3 | $20K | Buy |
46
+10
| +28% | +$4.35K | 0.01% | 550 |
|
|
2023
Q2 | $16K | Buy |
36
+3
| +9% | +$1.33K | ﹤0.01% | 617 |
|
|
2023
Q1 | $15.2K | Sell |
33
-18
| -35% | -$8.28K | ﹤0.01% | 625 |
|
|
2022
Q4 | $26.2K | Sell |
51
-21
| -29% | -$10.8K | 0.01% | 481 |
|
|
2022
Q3 | $33K | Buy |
72
+67
| +1,340% | +$30.7K | 0.01% | 475 |
|
|
2022
Q2 | $2K | Buy |
5
+4
| +400% | +$1.6K | ﹤0.01% | 954 |
|
|
2022
Q1 | $0 | Buy |
+1
| New | – | ﹤0.01% | 932 |
|